Park Ha Biological Technology Co., Ltd 6-K, filed Jun 23, 2026
Park Ha Biological Technology Co., Ltd. (BYAH)
About this 6-K
Park Ha Biological Technology Co., Ltd filed this 6-K on June 23, 2026.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2026
Commission File Number: 001-42453
Park Ha Biological Technology Co., Ltd.
901 & 901-2, Building C
Phase 2, Wuxi International Life Science Innovation Campus
196 Jinghui East Road
Xinwu District, Wuxi, Jiangsu Province
People’s Republic of China 214000
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Information Contained in this Form 6-K Report
Entry Into Strategic Partnership with Cloud Factory Technology Holdings Limited (02512.HK)
On June 23, 2026, Park Ha Biological Technology Co., Ltd. (the “Registrant”) announced that it had entered into a comprehensive strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK), a company listed on The Stock Exchange of Hong Kong.
The partnership is intended to jointly develop a specialized AI-driven ecosystem tailored for the beauty industry, leveraging cross-domain technological collaboration to transcend traditional growth limitations in the sector and usher in a new era of AI-powered and lean operations. The collaboration spans multiple areas, including organizational efficiency enhancement, store space utilization optimization, and AI-powered supply chain and inventory management improvements.
The foregoing description is qualified in its entirety by the press release attached as Exhibit 99.1 to this Form 6-K.
Issuance of Press Release
On June 23, 2026, the Registrant issued a press release announcing the strategic partnership described above. A copy of the press release is attached hereto as Exhibit 99.1.
Forward Looking Statements
Matters discussed in this report may constitute forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are not historical facts. Words such as “believes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or similar expressions identify forward-looking statements. The forward-looking statements in this report are based upon various assumptions. Although the Registrant believes that these assumptions were reasonable when made, they are inherently subject to significant uncertainties and contingencies that are difficult or impossible to predict and are beyond the Registrant’s control, the Registrant cannot assure you that it will achieve or accomplish these expectations. Actual results may differ materially from those anticipated. The Registrant undertakes no obligation to update or revise any forward-looking statements, except as required by law.
1
EXHIBIT INDEX
The following exhibit is being filed herewith:
| Exhibit No. | Description | |
| 99.1 | Press release of the Company dated June 23, 2026 |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Park Ha Biological Technology Co., Ltd. | ||
| Date: June 23, 2026 | By: | /s/ Xiaoqiu Zhang |
| Name: | Xiaoqiu Zhang | |
| Title: | Chief Executive Officer, Chairperson of the Board of Directors | |
3
Exhibit 99.1
Park Ha Biological Technology Co., Ltd. announces strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK) to build an AI-driven ecosystem for the beauty industry.
Wuxi, China, June 23, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced that the Company has established a comprehensive strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK), a company listed on The Stock Exchange of Hong Kong (“Cloud Factory”). The two parties will jointly develop a specialized AI-driven ecosystem tailored for the beauty industry, leveraging cross-domain technological collaboration to transcend traditional growth limitations in the sector and usher in a new era of AI-powered, lean operations.
The traditional offline beauty business model has long faced widespread operational challenges, including uneven customer distribution, excessive repetitive back-office tasks, and inventory management relying heavily on manual expertise. Relying solely on expanding new stores has progressively limited room for operational improvement. This collaboration aims to leverage AI computing capabilities to integrate accumulated brand operational data, implement digital operational tools, and enhance the efficiency of human and spatial resource utilization at both headquarters and store levels in a phased manner.
As an integrated technology provider spanning Internet Data Center (IDC) solutions, edge computing, and large-scale AI model adaptation platforms, Cloud Factory boasts extensive technical expertise and robust industry deployment capabilities. Leveraging its solid industrial technological foundation, the company has established long-term, stable, and deep collaborative partnerships with leading enterprises such as AMD and MetaX. Park Ha Biological, for its part, contributes deep domain expertise in skincare product development, franchise operations, and customer lifecycle management. By leveraging the complementary core strengths of both parties, the newly implemented vertical smart system for the beauty industry will achieve a comprehensive intelligent transformation of the brand management framework through two key dimensions: enhancing organizational efficiency and innovating store space utilization efficiency.
To enhance organizational efficiency, the system leverages intelligent data analytics, automated content generation, and smart research/reporting frameworks to eliminate extensive repetitive tasks. This is expected to boost backend operational efficiency in planning, operations, and marketing by up to 1.5 times in pilot implementations, enabling core teams to focus on high-value initiatives such as strategic planning, brand evolution, and system development, thereby optimizing talent allocation and decision-making speed.
Moving from back-office to front-of-house operations, in terms of store space efficiency optimization, leveraging big data analysis of customer traffic and intelligent scheduling algorithms, the system dynamically generates reference solutions for appointment management and staff shift optimization, helping stores balance reception arrangements across different time periods and mitigate resource underutilization during operating hours.
Beyond store-level optimization, the system also addresses supply chain and asset efficiency at a broader scale. At the supply chain and asset efficiency level, the AI-powered inventory system leverages real-time consumption data from retail outlets to accurately forecast demand and perform intelligent dynamic allocation, significantly enhancing overall inventory turnover efficiency while effectively reducing stock buildup, minimizing capital tie-up, and freeing up warehouse space in stores. Furthermore, by fully leveraging customer value throughout their lifecycle, it provides precise support across the entire customer journey—from acquisition and retention to order upselling and repeat purchases—achieving the lean operational goal of “maintaining current physical space while continuously boosting per-store revenue.”
This strategic collaboration marks a pivotal milestone for Park Ha Biological in transitioning from traditional “scale expansion-driven growth” to “data-driven, intelligent, and lean operational growth.” Moving forward, the Company will continue leveraging AI technology as its core growth engine, deeply integrating Cloud Factory’s smart manufacturing and supply chain capabilities, while continuously optimizing service standards, refining business models, enhancing user experience, and strengthening industry competitiveness. Amid the wave of digital transformation in the beauty sector, Park Ha Biological is committed to achieving sustainable, stable, and high-quality growth driven by technological innovation.
About Park Ha Biological Technology Co., Ltd.
Established in 2016, Park Ha Biological Technology Co., Ltd. is primarily engaged in developing its private skincare label, direct skincare product sales and franchise promotion under the proprietary brand “Park Ha”, with a commitment to providing cost-effective solutions to skin problems and improving the confidence of women in need of skin treatment. As of October 31, 2025, the Company has five directly operated stores and 22 franchisees in China. As part of its value-added service for the products, the Company offers “light beauty experience”, a quick complimentary after-sales beauty service performed in the directly operated stores and franchise stores. For more information, please visit the Company’s website: http://ir.parkha.cn/.
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects, “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions in this announcement. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC.
For more information, please contact:
Park Ha Biological Technology Co., Ltd.
901 & 901-2, Building C
Phase 2, Wuxi International Life Science Innovation Campus
196 Jinghui East Road
Xinwu District, Wuxi, Jiangsu Province
People’s Republic of China 214000
ir_parkha@163.com